|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.81 USD | +2.70% |
|
+2.07% | +1.02% |
| Jun. 09 | Nature's Sunshine Products files for offering of 2.8 mln shares | RE |
| Jun. 02 | Terrence Moorehead to Step Down as Chief Executive Officer of Nature?s Sunshine Products, Inc | CI |
Summary: Nature's Sunshine Products, Inc.
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Highlights: Nature's Sunshine Products, Inc.
- The company's profit outlook over the next few years is a strong asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses: Nature's Sunshine Products, Inc.
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings Chart: Nature's Sunshine Products, Inc.
Source: Surperformance
| Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
|---|---|---|---|---|---|
| - | - | 266M | |||
| 11.43B | |||||
| 9.4B | |||||
| 3.26B | |||||
| 2.63B | |||||
| - | 1.14B | ||||
| Average | 4.69B | ||||
| Weighted average by Cap. |
Investor (Composite)
-
Trader (Composite)
ESG MSCI
-
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
-
Net Margin
Financial Health (Composite)
-
Valuation
P/E
EV/Revenue
-
EV/EBITDA
-
PBR
-
Dividend Yield
-
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- NATR Stock
- Ratings Nature's Sunshine Products, Inc.
Select your edition
All financial news and data tailored to specific country editions
